Azelastine Hydrochloride

Specifications

79307-93-0CAS Number

253-720-4EC Number

4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one;hydrochlorideIUPAC Name

C22H25Cl2N3OChemical Formula

418.4 g/molMolecular Weight

AZELASTINE HYDROCHLORIDE; 79307-93-0; AZELASTINE HCl; Astepro; W-2979M; DTXSID2045945; E-0659; ASTEPRO ALLERGY; 0L591QR10I; 4-(p-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)-phthalazinone monohydrochloride; CHEBI:2951; DTXCID0025945; 1(2H)-Phthalazinone, 4-((4-chlorophenyl)methyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-, monohydrochloride; Rhinolast allergy; RefChem:54398; Children Astepro Allergy; Children's astepro allergy; Azelastine Hydrochloride Ophthalmic Solution 0.05%; 4-((4-chlorophenyl)methyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)-phthalazinone HCl; 253-720-4; 4-((4-Chlorophenyl)methyl)-2-((4RS)-(1-methylazepan-4-yl))phthalazin-1(2H)-one monohydrochloride; Astelin; Optivar; Rhinolast; Azelastine (hydrochloride); Allergodil; Azeptin; 37932-96-0; 4-(4-chlorobenzyl)-2-(1-methylazepan-4-yl)phthalazin-1(2H)-one hydrochloride; 4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one;hydrochloride; MFCD00242783; Optilast; 4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one hydrochloride; NCGC00095173-01; 4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)-1,2-dihydrophthalazin-1-one hydrochloride; SMR000469183; CAS-79307-93-0; Radethazin; Corifina; Optilas; Zalastine; C22H25Cl2N3O; Azep; SR-01000762975; Lasticom;; Astelin;; Azeptin;; Azel;; Astelin (TN); EINECS 253-720-4; Azelastine hydrochloride [USAN:JAN]; CPD000469183; 4-[(4-Chlorophenyl)methyl]-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)-phthalazinone hydrochloride; Azelastine hydrochloride CRS; SCHEMBL36770; MLS001401427; MLS006010756; SPECTRUM1505340; UNII-0L591QR10I; orb1223994; orb1310831; CHEMBL1200809; SCHEMBL29375717; HY-B0462R; MSK10899A; GLXC-02520; HMS1922F04; HMS5081M21; Pharmakon1600-01505340; 4-[(4-chlorophenyl)methyl]-2-[(4R)-1-methylazepan-4-yl]-1,2-dihydrophthalazin-1-one hydrochloride; 4-[(4-chlorophenyl)methyl]-2-[(4S)-1-methylazepan-4-yl]-1,2-dihydrophthalazin-1-one hydrochloride; Azelastine HCl - Bio-X trade mark; HY-B0462; Tox21_111469; AZELASTINE HYDROCHLORIDE [MI]; CCG-40046; EBC-11202; NSC758971; T0211L; Azelastine hydrochloride (JP18/USP); AZELASTINE HYDROCHLORIDE [JAN]; AKOS015895420; Azelastine (hydrochloride) (Standard); Tox21_111469_1; AC-5498; AZELASTINE HYDROCHLORIDE [USAN]; CCG-100841; FA64952; NC00091; W- 979M; AZELASTINE HYDROCHLORIDE [MART.]; AZELASTINE HYDROCHLORIDE [VANDF]; AZELASTINE HYDROCHLORIDE [USP-RS]; AZELASTINE HYDROCHLORIDE [WHO-DD]; NCGC00095173-02; NCGC00177979-05; 4-((4-Chlorophenyl)methyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)phthalazin-1(2H)-one hydrochloride; AS-14079; BA164232; SY009775; Azelastine hydrochloride, >=98% (HPLC); DB-262594; A2340; A9818; NS00088597; S2552; SW197471-3; AZELASTINE HYDROCHLORIDE [ORANGE BOOK]; AZELASTINE HYDROCHLORIDE [EP MONOGRAPH]; AZELASTINE HYDROCHLORIDE [USP MONOGRAPH]; C76537; D00659; DYMISTA COMPONENT AZELASTINE HYDROCHLORIDE; EN300-7359563; F053552; SR-01000762975-4; Q27105897; Z2074910255; Azelastine Hydrochloride 1.0 mg/ml in Methanol (as free base); 4-(4-Chlorobenzyl)-2-(1-methylazepan-4-yl)-1-phthalazinone Hydrochloride; Azelastine hydrochloride, European Pharmacopoeia (EP) Reference Standard; 4-(4-Chlorobenzyl)-2-(1-methyl-4-azepanyl)-1(2h)-phthalazinone hydrochloride (1:1); 4-(4-chlorobenzyl)-2-(1-methylazepan-4-yl)phthalazin-1(2H)-onehydrochloride; 4-[(4-Chlorophenyl)methyl]-2-(1-methyl-4-azepanyl)phthalazin-1-one Hydrochloride; Azelastine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; Azelastine hydrochloride, United States Pharmacopeia (USP) Reference Standard; 4-[(4-Chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1(2H)-one--hydrogen chloride (1/1)Synonyms